pharma · Pterygium · Open Angle Glaucoma
Zhongshan Ophthalmic Center
Zhongshan Ophthalmic Center, Sun Yat-sen University
Zhongshan Ophthalmic Center is a pharma organization headquartered in CN. Primary therapeutic focus areas include Pterygium, Open Angle Glaucoma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 paten
Guangzhou, CN HQ
85 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Employees
- 85
- Programs
- 2
- Drugs
- 5
- Patents
- 0
0.1% bromfenac
Approved · small molecule · Pterygium
0.1% bromfenac for Pterygium is a Approved program (small_molecule) at Zhongshan Ophthalmic Center, Sun Yat-sen University with 1 ClinicalTrials.gov record(s).
Internal code 2018KYPJ101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Pterygium
- Status
- completed
- Trials
- 1